BURHANETTİN UYSAL, Mustafa DEMİRKIRAN, Mehmet YORULMAZ

Assessing of Factors Effecting COVID-19 Mortality Rate on a Global Basis

In this study, it was aimed to investigate the effect of some health indicators of selected countries on COVID-19 pandemic death/case rates. In this study, which was conducted using retrospective data, the health indicators of countries with more than 50,000 COVID-19 cases were compared with the COVID-19 cases and death rates in these countries. The data used in the research process were obtained by the World Health Organization, the World Bank, and OECD sources. Results: Considering the findings obtained in the analysis, the USA ranks first in the highest number of deaths (89271), while Saudi Arabia is the last (329). The highest rate of death/case belongs to France (19.8), the lowest rate to Saudi Arabia (0.5%). In the correlation analysis based on the death/case ratio, a significant relationship was found in cancer deaths, congenital life expectancy, life expectancy above 65 years old, population 65 years and older (positive direction), and air pollution variables (negative direction). According to the results of the regression analysis for meaningful relationship variables, all independent variables affect the death/case ratio. The highest influencing variable is congenital life expectancy (R2 = ,462). As a result, deaths from cancer and especially congenital life expectancy and population over 65 years of age have a positive effect on COVID-19 death/case ratio. In this context, it is necessary to continue taking measures to protect the elderly population and individuals with chronic anxiety.

COVID-19 Ölüm Hızını Etkileyen Faktörlerin Küresel Bazda Değerlendirilmesi

Bu çalışmada, seçilmiş ülkelerin bazı sağlık göstergelerinin COVID-19 pandemisi ölüm/vaka oranları üzerindeki etkisinin araştırılması amaçlanmıştır. Retrospektif veriler kullanılarak yapılan bu çalışmada, 50.000'den fazla COVID-19 vakası olan ülkelerin sağlık göstergeleri ve bu ülkelerdeki ölüm oranları ile karşılaştırılmıştır. Araştırma sürecinde kullanılan veriler Dünya Sağlık Örgütü, Dünya Bankası ve OECD kaynakları tarafından elde edilmiştir. Analizden elde edilen bulgular göz önüne alındığında, ABD ölüm sayısında (89271) birinci sırada yer alırken, Suudi Arabistan son sıradadır (329). En yüksek ölüm/vaka oranı Fransa'ya (% 19,8), en düşük ölüm oranı ise Suudi Arabistan'a (% 0,5) aittir. Ölüm/vaka oranına dayalı korelasyon analizinde kanser ölümleri, doğumdan yaşam beklentisi, 65 yaş üstü yaşam beklentisi, 65 yaş ve üstü nüfus (pozitif yönde) ve hava kirliliği değişkenleri (negatif yönde) arasında anlamlı bir ilişki bulunmuştur. Anlamlı ilişki bulunan değişkenler için yapılan regresyon analizi sonuçlarına göre, tüm bağımsız değişkenler ölüm/vaka oranını etkilemektedir. En fazla etki eden değişken, doğumdan yaşam beklentisidir (R2 = ,462). Sonuç olarak kanserden ölümler ve özellikle doğumdan yaşam beklentisi ve 65 yaş üstü nüfus, COVID-19 ölüm vaka oranları üzerinde olumlu bir etkiye sahiptir. Bu bağlamda, yaşlı nüfusu ve kronik anksiyetesi olan bireyleri korumak için önlemler almaya devam etmek gerekmektedir.

PDF

___

Al-Ahdal, M.N., Al-Qahtani, A.A., & Rubino, S. (2012). Coronavirus respiratory illness in Saudi Arabia. The Journal of Infection in Developing Countries, 6(10), 692-694. https://doi.org/10.3855/jidc.3084

Armitage, R., & Nellums, L.B. (2020). COVID-19 and the consequences of isolating the elderly. The Lancet. Public health, 5(5), e256. https://doi.org/10.1016/S2468-2667(20)30061-X

Cascella, M., Rajnik, M., Cuomo, A., et al. (2020). Features, evaluation and treatment coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/

Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020). Convalescent plasma as a potential therapy for COVID-19. The Lancet, 20(4), 398-400. https://doi.org/10.1016/S1473-3099(20)30141-9

European Centre for Disease Prevention and Control. (2020). Q & A on COVID-19. https://www.ecdc.europa.eu/en/covid-19/questions-answers Fung, T.S., & Liu, D.X. (2019). Human coronavirus: Host-pathogen interaction. Annual Review of Microbiology, 73, 529-557. https://doi.org/10.1146/annurev-micro-020518-115759

General Office of National Health Committee (2020). Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 4).

Gondauri, D., & Batiashvili, M. (2020). The study of the effects of mobility trends on the statistical models of the COVID-19 virus spreading. Electronic Journal of General Medicine, 17(6): em243. https://doi.org/10.29333/ejgm/8212

Jin, Y.H., Cai, L., Cheng, Z.S., Cheng, H., Deng, T., Fan, Y.P., et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version), Military Medical Research, 7(4), 1-23. https://doi.org/10.1186/s40779- 020-0233-6

Kelvin, D.J., & Rubino, S. (2020). Fear of the novel coronavirus. The Journal of Infection in Developing Countries, 14(1), 1-2. https://doi.org/10.3855/jidc.12496

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020). Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 282(13), 1199-1207. https://doi.org/10.1056/NEJMoa2001316

Murthy, S., Gomersall, C.D., & Fowler, R.A. (2020). Care for critically ill patients with COVID-19. JAMA, 323(15), 1499-1500. https://doi.org/10.1001/jama.2020.3633

OECD. (2020a). OECD Data. https://data.oecd.org

OECD. (2020b). Life expectancy at birth. https://data.oecd.org/healthstat/life-expectancy-atbirth.htm

OECD. (2020c). Deaths from cancer. https://data.oecd.org/healthstat/deaths-from-cancer.htm

OECD. (2020d). Air pollution exposure. https://data.oecd.org/air/air-pollution-exposure.htm

Ong, S.W.X., Tan, Y.K., Chia, P.Y., Lee, T.H., Ng, O.T., et al. (2020). Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA, 323(16), 1610-1612. https://doi.org/10.1001/jama.2020.3227

Sabino-Silva, R., Jardim, A.C.G., & Siqueira, W.L. (2020). Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical Oral Investigations, 24, 1619-1621. https://doi.org/10.1007/s00784-020-03248-x

Shaw, R., Kim, Y., & Hua, J. (2020). Governance, technology and citizen behavior in pandemic: Lessons from COVID-19 in East Asia. Progress in Disaster Science, 6. https://doi.org/10.1016/j.pdisas.2020.100090

Studdert, D. M., & Hall, M. A. (2020). Disease control, civil liberties, and mass testing - calibrating restrictions during the Covid-19 pandemic. The New England journal of medicine, 383, 102- 104. https://doi.org/10.1056/NEJMp2007637

Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, 92(4), 441-447. https://doi.org/10.1002/jmv.25689

WHO. (2020). Indicators. https://www.who.int/data/gho

WHO. (2020a). Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak: Interim guidance. 29 January 2020. https://apps.who.int/iris/handle/10665/330987

WHO. (2020b). Coronavirus disease (COVID-19), Situation report–121. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200520-covid19-sitrep-121.pdf?sfvrsn=c4be2ec6_4

WHO. (2020c). Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 World Bank. (2020). Indicators. https://data.worldbank.org/indicator